Ashley L. Andrews
No Rating Available
(Learn About Our Rating System)

Ashley L. Andrews, DNP, CPNP

Languages spoken: English

Clinical Locations

Primary Location

Eccles Primary Children's Outpatient Services

81 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-213-3599
Get Directions

  • Ashley Andrews is a Pediatric Nurse Practitioner board certified by the Pediatric Nursing Certified Board. She has Bachelor of Science in Health Sciences with concentration in disease prevention and health promotion. She then earned her Bachelor of Science in Nursing and Mater of Science in Nursing from California State University, Long Beach. Ashley joined the University of Utah in 2013. She is experienced in a wide range of inborn errors of metabolism including phenylketonuria, organic acidemias, urea cycle disorders, fatty acid oxidation defects, glycogen storage diseases and lysosomal storage disorders. She is particularly engaged in the concept of transitioning to self-care and works to include children in the management of their chronic condition from an early age.

    Ashley is also an active contributor and coordinator, for the Penelope Undiagnosed Disease Program, including the NIH sponsored Undiagnosed Disease Network.

    Specialties

    Board Certification

    Pediatric Nursing Certification Board

  • Ashley Andrews is a Pediatric Nurse Practitioner board certified by the Pediatric Nursing Certified Board. She has Bachelor of Science in Health Sciences with concentration in disease prevention and health promotion. She then earned her Bachelor of Science in Nursing and Mater of Science in Nursing from California State University, Long Beach. Ashley joined the University of Utah in 2013. She is experienced in a wide range of inborn errors of metabolism including phenylketonuria, organic acidemias, urea cycle disorders, fatty acid oxidation defects, glycogen storage diseases and lysosomal storage disorders. She is particularly engaged in the concept of transitioning to self-care and works to include children in the management of their chronic condition from an early age.

    Ashley is also an active contributor and coordinator, for the Penelope Undiagnosed Disease Program, including the NIH sponsored Undiagnosed Disease Network.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Advanced Practice Clinician
    Academic Divisions Medical Genetics
    Board Certification
    Pediatric Nursing Certification Board

    Education history

    Undergraduate Major: Disease Prevention, Health Promotion; Minor: Psychology - California State University, Fullerton B.S.
    Undergraduate Nursing - California State University, Long Beach BSN
    Graduate Training Pediatric Nurse Practitioner - California State University, Long Beach MScN
    Professional Medical Nursing - University of Utah College of Nursing DNP

    Selected Publications

    Journal Article

    1. Lewis RG, O'Shea JM, Pizzo L, Wen T, Fulmer ML, Zhao J, Verheijen J, Zhang C, Velinder M, Nicholas TJ, Boyden SE, Ward A, Baldwin EE, Andrews A, Ruiz JH, Marchetti M, Viskochil D, Carey JC, Bleyl SB, Butterfield RJ, Taliercio V, Botto LD, Mao R, Bayrak-Toydemir P, Undiagnosed Diseases Networ (2025). RNA sequencing provides functional insights and diagnostic resolution in previously unsolved rare disease cases. BMC medical genomics, 18(1), 182. (Read full publication)
    2. Wen T, Boyden SE, Hocutt CM, Lewis RG, Baldwin EE, Vagher J, Andrews A, Nicholas TJ, Chapin A, Fan EM, Botto LD, Bayrak-Toydemir P, Mao R, Meznarich J (2025). Identification of 2 novel noncoding variants in patients with Diamond-Blackfan anemia syndrome by whole genome sequencing. Blood advances, 9(10), 2443-2452. (Read full publication)
    3. Patterson WG, Offord SJ, Buch LD, Lewis GM, Andrews A, Sparks KB, Cooley Coleman JA, Tribble L (2024). Advanced practice providers in the medical genetics workforce: A nationwide survey. Genetics in medicine, 26(12), 101254. (Read full publication)
    4. Andrews A, McMinimee (2024). Navigating social determinants of health barriers in the management of phenylketonuria. Molecular genetics and metabolism reports, 39(Suppl 1), 101080. (Read full publication)
    5. Zhao J, Longo N, Lewis RG, Nicholas TJ, Boyden SE, Andrews A, Larson A, Undiagnosed Diseases Network, Bayrak-Toydemir P, Botto LD, Mao (2024). Novel molecular mechanism in Malan syndrome uncovered through genome sequencing reanalysis, exon-level Array, and RNA sequencing. American journal of medical genetics. Part A, 194(5), e63516. (Read full publication)
    6. Andrews A, Roberts S, Botto L (2022). Benefits of tailored disease management in improving tremor, white matter hyperintensities, and liver enzymes in a child with heterozygous X-linked ornithine transcarbamylase deficiency. Molecular genetics and metabolism reports, 33(Suppl 1), 100891. (Read full publication)
    7. Coughlin CR, Tseng LA, Bok LA, Hartmann H, Footitt E, Striano P, Tabarki BM, Lunsing RJ, Stockler-Ipsiroglu S, Gordon S, Van Hove JLK, Abdenur JE, Boyer M, Longo N, Andrews A, Janssen MCH, van Wegberg A, Prasad C, Prasad AN, Lamb MM, Wijburg FA, Gospe SM Jr, van Karnebeek C, International PDE Consortiu (2022). Association Between Lysine Reduction Therapies and Cognitive Outcomes in Patients With Pyridoxine-Dependent Epilepsy. Neurology, 99(23), e2627-e2636. (Read full publication)
    8. Helman G, Zarekiani P, Tromp SAM, Andrews A, Botto LD, Bonkowsky JL, Chassevent A, Giorgio E, Pippucci T, Wei S, Smith-Hicks C, Vaula G, Willemsen MAAP, Schimmel M, Vollert K, Shimizu F, Kanda T, Lynch M, Roscioli T, Taft RJ, Simons C, Bugiani M, Kuijpers TW, van der Knaap M (2022). Heterozygous NOTCH1 Variants Cause CNS Immune Activation and Microangiopathy. Annals of neurology, 92(5), 895-901. (Read full publication)
    9. Tseng LA, Hoytema van Konijnenburg EMM, Longo N, Andrews A, van Wegberg A, Coene KLM, Coughlin CR 2nd, van Karnebeek CD (2022). Clinical Reasoning: Pediatric Seizures of Unknown Cause. Neurology, 98(24), 1023-1028. (Read full publication)
    10. Tseng LA, Abdenur JE, Andrews A, Aziz VG, Bok LA, Boyer M, Buhas D, Hartmann H, Footitt EJ, Grønborg S, Janssen MCH, Longo N, Lunsing RJ, MacKenzie AE, Wijburg FA, Gospe SM Jr, Coughlin CR 2nd, van Karnebeek CD (2022). Timing of therapy and neurodevelopmental outcomes in 18 families with pyridoxine-dependent epilepsy. Molecular genetics and metabolism, 135(4), 350-356. (Read full publication)
    11. Di Sera T, Velinder M, Ward A, Qiao Y, Georges S, Miller C, Pitman A, Richards W, Ekawade A, Viskochil D, Carey JC, Pace L, Bale J, Clardy SL, Andrews A, Botto L, Marth (2021). Gene.iobio: an interactive web tool for versatile, clinically-driven variant interrogation and prioritization. Scientific reports, 11(1), 20307. (Read full publication)
    12. Hagen-Lillevik S, Rushing JS, Appiah L, Longo N, Andrews A, Lai K, Johnson (2021). Pathophysiology and management of classic galactosemic primary ovarian insufficiency. Reproduction & fertility, 2(3), R67-R84. (Read full publication)
    13. Häberle J, Moore MB, Haskins N, Rüfenacht V, Rokicki D, Rubio-Gozalbo E, Tuchman M, Longo N, Yandell M, Andrews A, AhMew N, Caldovic (2021). Noncoding sequence variants define a novel regulatory element in the first intron of the N-acetylglutamate synthase gene. Human mutation, 42(12), 1624-1636. (Read full publication)
    14. Manzoni F, Salvatici E, Burlina A, Andrews A, Pasquali M, Longo (2020). Retrospective analysis of 19 patients with 6-Pyruvoyl Tetrahydropterin Synthase Deficiency: Prolactin levels inversely correlate with growth. Molecular genetics and metabolism, 131(4), 380-389. (Read full publication)
    15. Carlston CM, Bleyl SB, Andrews A, Meyers L, Brown S, Bayrak-Toydemir P, Bale JF, Botto L (2019). Expanding the genetic and clinical spectrum of the NONO-associated X-linked intellectual disability syndrome. American journal of medical genetics. Part A, 179(5), 792-796. (Read full publication)
    16. Yuzyuk T, Viau K, Andrews A, Pasquali M, Longo (2018). Biochemical changes and clinical outcomes in 34 patients with classic galactosemia. Journal of inherited metabolic disease, 41(2), 197-208. (Read full publication)
    17. Andrews A, Christensen SS, Lubeznik-Warner R (2025). Enhancing mental health screening practices for adolescents with phenylketonuria: A quality-improvement initiative. Journal of the American Association of Nurse Practitioners, (Read full publication)